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219 ABSTRACT 
20 Study question: 
21 How has the timing of womens reproductive events (including ages at menarche, first birth, and 
22 natural menopause, and the number of children) changed across birth years, racial/ethnic groups and 
23 educational levels?
24 Summary answer: 
25 Women who were born in recent generations (1970-84 vs before 1930) or those who with higher 
26 education levels had menarche a year earlier, experienced a higher prevalence of nulliparity and had 
27 their first child at a later age.
28 What is known already: 
29 The timing of key reproductive events, such as menarche and menopause, is not only indicative of 
30 current health status but is linked to the risk of adverse hormone-related health outcomes in later life.
31 Variations of reproductive indices across different birth years, race/ethnicity and socioeconomic 
32 positions have not been described comprehensively.
33 Study design, size, duration: 
34 Individual-level data from 23 studies that contributed to the International Collaboration for a Life 
35 Course Approach to Reproductive Health and Chronic Disease Events (InterLACE) consortium were 
36 included. 
37 Participants/materials, setting, methods: 
38 Altogether 505,147 women were included. Overall estimates for reproductive indices were obtained 
39 using a two-stage process: individual-level data from each study were analysed separately using 
40 generalised linear models, with these estimates were combined using random-effects meta-analyses.
41 Main results and the role of chance: 
42 Mean ages were 12.9 years at menarche, 25.7 years at first birth, and 50.5 years at natural menopause, 
43 with significant between-study heterogeneity (I2>99%). A linear trend was observed across birth year 
44 for mean age at menarche, with women born from 1970-84 having menarche one year earlier (12.6 
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345 years) than women born before 1930 (13.5 years). The prevalence of nulliparity rose progressively 
46 from 14% of women born from 1940-49 to 22% of women born 1970-84; similarly, the mean age at 
47 first birth rose from 24.8 to 27.3 years. Women with higher education levels had fewer children, later 
48 first birth, and later menopause than women with lower education levels. After adjusting for birth 
49 year and education level, substantial variation was present across racial/ethnic/regional groups.   
50 Limitations, reasons for caution: 
51 Variations of study design, data collection methods, and sample selection across studies, as well as 
52 retrospectively reported age at menarche, age at first birth may cause some bias.
53 Wider implications of the findings: 
54 This global consortium study found robust evidence on variations in reproductive indices for women 
55 born in the 20th century that appear to have both biological and social origins.
56 Study funding/competing interest(s): 
57 InterLACE project is funded by the Australian National Health and Medical Research Council project 
58 grant (APP1027196). GDM is supported by the Australian National Health and Medical Research 
59 Council Principal Research Fellowship (APP1121844).
60
61 Keywords: reproductive events; age at menarche; first birth; age at menopause; number of children
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462 INTRODUCTION
63 Reproductive health is integral to womens overall health and wellbeing and has consequences over 
64 the life course. The timing of key reproductive events, such as menarche and menopause, is not only 
65 indicative of current health status but is linked to the risk of adverse hormone-related health outcomes 
66 in later life, including breast cancer, endometrial cancer, type 2 diabetes and cardiovascular disease 
67 (Atsma et al., 2006, Brand et al., 2013, Charalampopoulos et al., 2014, Collaborative Group on 
68 Hormonal Factors in Breast Cancer, 2012, Janghorbani et al., 2014, Muka et al., 2017, Parkin, 2011). 
69 Identifying key variations in the occurrence and timing of reproductive events across and within 
70 populations assists with understanding the impact of socioeconomic changes (e.g. cohort effects and 
71 socioeconomic disparities) as well as cultural/environmental exposures and genetic effects (e.g. 
72 race/ethnicity and residential country) on women and has implications for the provision of health 
73 services and preventive health strategies.
74
75 A previous World Health Organisation (WHO) multicentre hospital-based study, and meta-analyses 
76 of community-based studies, concluded that a typical woman had menarche at age 14, her first birth 
77 at 22, and reached natural menopause at age 49-50 years, with a substantial international variation in 
78 the timing of these events (Morabia and Costanza, 1998, Schoenaker et al., 2014, Thomas et al., 
79 2001). Variations across birth years indicate that age at menarche is declining and that more recent 
80 generations have delayed childbirth (Hosokawa et al., 2012, Mathews and Hamilton, 2016, Morris et 
81 al., 2011), but such trends have not been demonstrated consistently across countries (Juul et al., 2006, 
82 Rubin et al., 2009). Available studies of women with complete reproductive histories have lacked 
83 data on racial/ethnic diversity, as well as comparative data across cohorts. Socioeconomic 
84 differentials are also evident for parity, age at first birth, and possibly age at menopause; however, 
85 the degree and significance of these differentials vary from country to country according to its level 
86 of economic development, and within each country from generation to generation of women (dos 
87 Santos Silva and Beral, 1997).
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89 The International Collaboration for a Life Course Approach to Reproductive Health and Chronic 
90 Disease Events (InterLACE) has pooled individual-level data from 10 countries. This global 
91 consortium provides unparalleled statistical power and comparative information on reproductive 
92 events across birth years and diverse racial/ethnic groups. Our objective was to describe the variability 
93 in the occurrence and timing of womens reproductive events (including age at menarche, first birth, 
94 and natural menopause, and the number of children) within and between study populations as well as 
95 by birth year, racial/ethnic/regional groups, and education level. If there are substantial variations by 
96 these factors, it may point to the potential role of cohort effects, cultural/environmental exposures 
97 and genetic effects, and other influences such as secular trends in education level over time.
98
99 MATERIALS and METHODS
100 Ethical approval 
101 Participants in each of the included studies were recruited and provided consent according to the 
102 approved protocols of the Institutional Review Board or the Human Research Ethics Committee at 
103 each relevant institution.
104
105 Study populations
106 InterLACE has brought together a total of 25 observational studies of womens health, of which eight 
107 are cross-sectional, and 17 include longitudinal data. Detailed descriptions of the InterLACE 
108 collaboration, the included studies and the harmonisation process to combine data at the individual-
109 level have been published previously (Mishra et al., 2013, Mishra et al., 2016). Briefly, observational 
110 studies, which had collected prospective or retrospective survey data on womens reproductive health 
111 across the lifespan (such as ages at menarche, first birth, and natural menopause), socio-demographic 
112 and lifestyle factors, and chronic disease events, could contribute data to the InterLACE consortium, 
113 regardless of the sample size and ethnic background of participants. Each study contributed 
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6114 individual-level data. Key variables were harmonised into the simplest level of detail that would 
115 incorporate information from as many as studies as possible. Overall, anonymised data from over 
116 537,000 women were pooled from Australia (n=53,299), Europe (n=427,089, including UK 
117 n=343,155), USA (n=5,444), Middle-East (n=597), and Japan (n=50,774). 
118
119 Of the 25 studies, the San Francisco Midlife Womens Health Study (n=347) and the Japanese Midlife 
120 Womens Health Study (n=847) were excluded as data on age at menarche and/or age at natural 
121 menopause are not currently available, with 23 studies included in the present study. Around 6% of 
122 the women (n=30,862) who did not have data on both age at menarche and age at natural menopause 
123 were excluded, leaving 504,147 women for the pooled analyses (Table 1). The analysis sample for 
124 each reproductive marker was different depending on whether the events had occurred or not and was 
125 further adjusted for relevant covariates, including birth year, race/ethnicity/region, education level, 
126 smoking status, and body mass index (BMI). The percentages of women with missing covariate data 
127 were relatively small (<3%).    
128
129 Reproductive events
130 Questions on reproductive events were conceptually similar across studies, although the exact 
131 wording differed. Information on age at menarche, age at first birth (live birth), and parity (number 
132 of children or live births) were collected prospectively in three British birth cohort studies (NSHD, 
133 NCDS, and BCS70), but were retrospectively assessed in all other studies. Information on age at 
134 menopause was obtained prospectively where possible. Age at natural menopause was defined as the 
135 age at the final menstrual period (confirmed after 12 months of cessation of menses) and was distinct 
136 from the cessation of menses due to radiation treatment, bilateral oophorectomy, or hysterectomy. 
137 When age at natural menopause was reported at multiple surveys in longitudinal studies, the response 
138 to the last available survey was used to ensure the final menstrual age was identified (Mishra et al., 
139 2016). 
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141 Factors assessed for variability
142 Variability in reproductive events was assessed according to womens year of birth, 
143 racial/ethnic/regional groups, and education levels. Birth year ranged from 1900 to 1984 and was 
144 categorised as born before 1930, 1930-39, 1940-49, 1950-59, 1960-69, and 1970 onwards. 
145 Race/ethnicity was derived from self-identified racial/ethnic background reported in 13 studies. For 
146 the remaining studies, race/ethnicity was defined based on the reported country of birth, the language 
147 spoken at home, or the country where the study was conducted (residency) (Mishra et al., 2016). For 
148 instance, although InterLACE currently has no studies from China, a group of women  who were 
149 categorised as Chinese as per above  were Chinese living or born in Australia (AU), UK, and USA. 
150 Accordingly racial/ethnic/regional groups were identified as Caucasian (AU), Caucasian (Europe), 
151 Caucasian (USA), African/Black (Europe/USA), Japanese (AU/UK/USA  only nine Japanese from 
152 AU), Japanese (Japan), Chinese (AU/UK/USA), South Asian (AU/UK), Southeast Asian 
153 (AU/UK/USA), Middle Eastern (AU/UK/Middle East  one-third from AU/UK), Hispanic/Latino 
154 (AU/UK/USA), and Other (including Aboriginal, Pacific Islander, Native American, Hawaiian, and 
155 mixed) (Mishra et al., 2016). Education level was harmonised as no formal education, year 10 or 
156 equivalent, year 12 or equivalent, trade/certificate/diploma or vocational education, and 
157 college/university or higher.  
158
159 Statistical analysis
160 Although individual participant data were available for all studies, it was not possible to use 
161 multilevel mixed models to obtain aggregate estimates across the studies because the data were very 
162 unbalanced. For example, all participants in some studies were born in the same decade, or in other 
163 studies, all participants belonged to the same racial/ethnic/regional group. Instead, a two-stage 
164 method of analysis was used. 
165
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8166 In the first stage, the data from each study were analysed separately, using relevant design weights if 
167 available (ALSWH 1946-51 and 1973-78 cohorts) and appropriate generalised linear models. In each 
168 study, the crude mean ages at menarche, first birth, and natural menopause were estimated, and further 
169 stratified by birth year, race/ethnicity/region, and (with exception for age at menarche) education 
170 level and adjusted for relevant covariates (described below) using linear regression models. The 
171 decade of the womans year of birth and race/ethnicity/region were included as covariates in all 
172 models. In addition, the level of education was included in the model for age at first birth; while the 
173 model for age at natural menopause included level of education, smoking status (never, past, and 
174 current smoker), and BMI (underweight, normal, overweight, and obese) at the baseline survey. Age 
175 at menarche and parity were further included in the models for age at menopause only for studies 
176 with data on both variables. The distribution of parity and the median number of children for parous 
177 women were also reported for each study. The proportions of women with no children (nulliparity) 
178 were also stratified by these key factors.
179
180 In the second stage, the crude mean estimates from each study were combined using random-effects 
181 meta-analysis (with study as the random effect) to obtain overall pooled estimates, with the forest 
182 plots presented in Fig. 1. The adjusted mean ages at menarche, first birth, and menopause and the 
183 proportions of nulliparity (unadjusted) were also combined from each study using random-effects 
184 meta-analyses by womens year of birth, racial/ethnic/regional group, and education level (Figs. 2-
185 5). In other words, for each category of the covariates (year of birth, racial/ethnic/regional group, and 
186 education level) the figures show the study-specific means of the outcome variables pooled from 
187 studies with available data. Between-study heterogeneity was assessed using chi-square (Cochrane 
188 Q) and I2 statistics (Higgins et al., 2003, Palmer and Sterne, 2015).
189
190 Eleven studies included women who were younger than 40 years at final follow-up, who could, 
191 therefore, still have experienced reproductive events, such as giving birth to their first child and 
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9192 particularly natural menopause, after this time point. To avoid this source of sample bias, data on 
193 parity and age at first birth were only included in the analysis from women aged N)* years at last 
194 follow-up and data on age at natural menopause only from women aged N66 years at last follow-up. 
195 A sensitivity analysis was performed using the first and the last reported age at menopause (where 
196 the reported age varied between different surveys). Survival analysis was also performed for each 
197 study with no restricted criteria on age at last follow-up and including pre- or perimenopausal women 
198 in the analysis (total sample=373,154). Reported age at menopause was used as outcome, and women 
199 were censored at the age of medical interventions (e.g. hysterectomy or bilateral oophorectomy) that 
200 led to menopause, or age at loss to follow-up or the end of the study for women who were pre- or 
201 perimenopausal at the last follow-up. The study-specific mean estimates were then pooled using 
202 random-effects meta-analysis. Generalised linear models were performed using SAS version 9.4, and 
203 meta-analyses were performed using Stata version 14.0 (Palmer and Sterne, 2015).
204
205 RESULTS
206 From the 23 studies, 505,147 women provided information on age at menarche and/or natural 
207 menopause and were included in the analyses. Women had a median baseline age of 52 years, ranging 
208 from 40 to 74 years across studies (Table 1). Except for the two contemporary cohorts of women 
209 born after 1970 and the French Three-City study of older adults, all studies included women born 
210 between 1940 and 1960, and this birth interval included the majority of women in InterLACE (69%). 
211 Several studies included women born earlier or later, with 11% of women across all studies born 
212 before 1940 and 20% after 1960. The majority of women in InterLACE had a Caucasian background 
213 (87%) (Table 2), with Japanese women identified as another major group (9.7%), followed by 
214 African American/Black (1.3%) and South Asian (0.9%). Across studies, almost one in four women 
215 (24.3%) had at least college or university degree, 23.0% had trade/certificate/diploma or vocational 
216 education, 12.3% had completed year 12, 34.6% had completed year 10, and 5.8% had no formal 
217 education (data not shown). 
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218
219 Age at menarche
220 Mean age at menarche for 493,395 women across 20 studies was 12.9 years (95% CI 12.7-13.0) with 
221 high heterogeneity evident between studies (I2=99.8%) (Fig. 1A). 
222
223 By year of birth: When mean age at menarche was stratified by year of birth (Fig. 2A), the pooled 
224 analyses showed a significant linear trend for earlier age at menarche with the later birth year that 
225 remained after adjusting for race/ethnicity/region (p for trend=0.0014). These adjusted results show 
226 that women born before 1930 had a mean age at menarche of 13.5 years (13.0-14.0), whereas women 
227 born from 1970 onwards (1970-84) experienced menarche an almost one year earlier at mean age 
228 12.6 years (12.3-13.1). The proportion of women with early age at menarche 3O years, n=91,528, 
229 18.6%) also increased from 12.5% for women born before 1930 to 19.8% for those born from 1970 
230 onwards.
231
232 By race/ethnicity/region: Age at menarche varied considerably across racial/ethnic/regional groups 
233 even after adjusting for birth year (Fig. 2B). For instance, Japanese women in the AU/UK/USA had 
234 the earliest mean age at menarche of 12.5 years (12.1-12.9), which was one year earlier than women 
235 in Japan who recorded the latest mean age at menarche (13.6 years, 13.2-14.0), but was similar to 
236 Caucasian women in the USA (12.6 years, 12.5-12.7). 
237
238 Parity
239 Across the 21 studies with information on parity (n=453,515), 16% of women reported having no 
240 children, 13% had one child, 43% had two, and 28% had three or more (Table 3). For 379,344 women 
241 with at least one child, the median number of children was 2 (IQR 2-3). 
242
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243 By year of birth: The proportion of nulliparous women stratified by year of birth suggests a shallow 
244 U-shape over time (Fig. 3A). For women born before 1930 the proportion of nulliparity was 19.3%, 
245 which decreased to 13.6% for women born in 1940-49, and then increased with birth year to 21.6% 
246 for women born from 1970 onwards. 
247
248 By race/ethnicity/region: Substantial variation in nulliparity was evident across racial/ethnic/regional 
249 groups (Fig. 3B). The lowest prevalence levels for nulliparity (8.1% to 10.3%) were seen for Middle 
250 Eastern, Hispanic/Latino, African American/Black, and South Asian women. 
251
252 By education level: Higher education levels were associated with nulliparity (p for trend=0.04) (Fig. 
253 3C). One in four (25.3%) women with college/university were nulliparous, compared with 9.3% for 
254 those with no formal education.
255
256 Age at first birth
257 Mean age at first birth for 364,742 parous women across 19 studies was 25.7 years (25.4-26.0) with 
258 significant between-study heterogeneity (I2=99.7%) (Fig. 1B). 
259
260 By year of birth: Age at first birth was statistically different across the mothers birth year groups 
261 even after adjusting for race/ethnicity/region and education level (Fig. 4A). Similar to the U-shape 
262 evident for nulliparity, the adjusted results show mean age at first birth was 27.2 years (25.4-28.9) 
263 for women born before 1930 and decreased to 24.8 years (23.7-25.9) for women born in 1940-49. 
264 Across subsequent birth decades, the adjusted mean age at first birth was progressively delayed to 
265 reach 27.3 years (26.6-28.0) for women born from 1970 onwards.
266
267 By race/ethnicity/region: Substantial variability was evident for age at first birth across different 
268 racial/ethnic/regional groups (Fig. 4B) even after adjusting for year of birth and education level. First 
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269 birth was reported at younger ages for Hispanic/Latino and African American/Black women (between 
270 23.7 and 24.1 years), whereas Chinese women in AU/UK/USA reported an adjusted mean age at first 
271 birth of 27.6 years. 
272
273 By education level: Higher education level was associated with later age at first birth, and this 
274 remained after adjusting for year of birth and race/ethnicity/region (Fig. 4C), with each step up in 
275 education category corresponding to a delay of about one year (p for trend=0.0028). For women with 
276 college/university degree, the adjusted mean age at first birth was 28.1 years (27.7-28.6), compared 
277 with 23.5 years (22.6-24.4) for women with no formal education.  
278
279 Age at natural menopause
280 Mean age at natural menopause for 172,125 women reporting natural menopause across 21 studies 
281 was 50.5 years (50.2-50.8) with significant between-study heterogeneity (I2=99.2%) (Fig. 1C). The 
282 pooled mean age at menopause using survival analysis was 50.9 years (50.6-51.2) (n=373,154; data 
283 now shown). The subsequent results decribed below for different factors were after mutual 
284 adjustments and also adjusted for smoking status and BMI.
285
286 By year of birth: No clear trend was observed in variability in age at natural menopause according to 
287 birth year, and this remained the case after adjusting for covariates (p for trend=0.22) (Fig. 5A). 
288
289 By race/ethnicity/region: Substantial variation was present in age at natural menopause across 
290 racial/ethnic/regional groups that remained after adjustment (Fig. 5B). Youngest mean ages at natural 
291 menopause occurred for South Asian (48.8 years), Middle Eastern, Southeast Asian, and African 
292 American/Black women (between 49.6 and 49.8 years) which persisted after further adjusting for 
293 menarche and parity, whereas highest mean ages were observed for Japanese (USA/UK) (51.4 years) 
294 and Japanese (Japan) (51.9 years). 
Page 41 of 68
http://humrep.oupjournals.org
Draft Manuscript Submitted to Human Reproduction for Peer Review
13
295
296 By education level: Age at natural menopause tended to occur later for women with higher education 
297 levels (p for trend=0.012), even after adjusting for year of birth, race/ethnicity/region, smoking and 
298 body weight (Fig. 5C). Women who received college/university education reporting an adjusted 
299 mean age at menopause of 50.6 years (50.2-51.0) compared with those who had no formal education 
300 reporting menopause at 49.9 years (49.4-50.4). The results remained after further adjustment for 
301 menarche and parity. 
302
303 DISCUSSION
304 In this global consortium study, individual-level data from over 500,000 women were used to analyse 
305 the variability in the timing of menarche, first birth, and menopause by birth year, 
306 racial/ethnic/regional group, and education level. On average women reached menarche at age 12.9 
307 years, had their first birth at 25.7 years, and experienced natural menopause at 50.5 years. This study 
308 provides the most robust evidence currently available on variations in these key reproductive indices 
309 across sociodemographic groups, including adjustment for relevant covariates. 
310
311 The variations by decade of birth year and education level point to cohort effects and socio-
312 environmental influence (especially socioeconomic changes) on markers of reproductive health. The 
313 mean age at menarche declined progressively with birth year, by almost one year from 13.5 years for 
314 women born before the 1930s to 12.6 years for the youngest women in the study, born from 1970 to 
315 1984. In contrast, however, a shallow U-shape was evident for both age at first birth and nulliparity 
316 which reached a minimum for women born in 1940-49, and then increased from age 24.8 years to 
317 over 27 years and from 14% to 22% respectively for women born from 1970 to 1984. This pattern 
318 reflects major economic and sociologic events. A higher proportion of nulliparity and higher age at 
319 first birth was evident during the great depression. In the decades after World War II, the rise in the 
320 level of educational attainment among women partly explains the trend to later childbearing and the 
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321 secular decline in birth rates, with an increase in the proportion of nulliparous women for the most 
322 educated (college/university degree) compared with the least educated (no formal education) and a 
323 decline in the percentage with three or more children (data not shown). Women with higher education 
324 levels also tended to experience natural menopause at a later age, after accounting for established 
325 factors such as parity and smoking status. 
326
327 The timing of reproductive events varied considerably by racial/ethnic/regional groups. These 
328 differences underscore the influence of cultural and early environmental exposures as well as 
329 biological/genetic factors on ages at menarche and menopause. For instance, Japanese women in 
330 AU/UK/USA had earlier ages at menarche (one year earlier) and menopause (half a year earlier) than 
331 their counterparts in Japan. Diet and lifestyle may partly explain the variations, as Japanese women 
332 living in the AU/UK/USA were more likely to be overweight (19.4% vs 11.1%) and obese (8.3% vs 
333 1.8%) compared with those living in Japan. It should be noted that Japanese from Australia 
334 contributed only a small proportion of the data (n=9) compared with UK and US. Similarly, after 
335 adjusting for birth year and education, Caucasian women in the USA having higher prevalence of 
336 nulliparity, earlier age at menarche, and later age at menopause than Caucasian women in Europe or 
337 Australia also highlights the potential role of cultural and other environmental influences. In addition, 
338 the impact of migration on physical and mental health may play a role in relation to reproductive 
339 events, as the majority of non-Caucasian racial/ethnic groups in this study were the first or second-
340 generation migrants living in Europe, Australia, and USA.   
341  
342 The findings on the timing of the reproductive events are in broad agreement, within the margins of 
343 error, with estimates from a recent individual-participant meta-analysis of 117 epidemiological 
344 studies from 35 countries on breast cancer risk (Collaborative Group on Hormonal Factors in Breast 
345 Cancer, 2012). That study found that cancer-free controls (over 300,000 women) had a mean age at 
346 menarche of 13.1 years (SD 1.7) and mean age at natural menopause of 49.3 years (SD 4.6). The 
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347 evidence of decreased age at menarche over time identified from InterLACE is also consistent with 
348 other studies (Euling et al., 2008, Forman et al., 2013, Liu et al., 2009, Yang et al., 2017). The 
349 findings here also indicate that the variability in the timing of reproductive events is influenced by a 
350 range of social and environmental factors, such as birth year and education levels. 
351
352 A number of limitations need to be acknowledged. Some differences in the study design, data 
353 collection methods, and sample selection may explain the observed variations across studies. For 
354 instance, the Whitehall II study from the UK comprised only women who were working for the civil 
355 service, with almost half reporting that they had no children. Similarly, the Japan Nurses Study was 
356 based on a sample from a single professional group. Furthermore, although prospective by design, 
357 most studies collected the information on menarche, age at first birth retrospectively (and in some 
358 cases age at menopause). Some recall and rounding errors in reporting these timings may have 
359 influenced our estimates. The bias is likely to be minimal since analysis using the first or the last 
360 reported age at menopause (where available) did not make any substantive difference to our results. 
361 Age at natural menopause obtained from repeated data in longitudinal studies was slightly later 
362 compared with studies in which it was reported retrospectively. However, it has been reported that 
363 women recall reproductive events, including age at first menses, with a high degree of accuracy. One 
364 validation study showed that nearly 80% of the women (mean age 42 years) precisely recalled their 
365 age at menarche to within one year of original menarche (55% within half a year of original menarche) 
366 (Must et al., 2002). In general, accuracy of recall is decreased with older age and lower education 
367 level. Another limitation is that the information on environmental chemicals (e.g. endocrine-
368 disrupting chemicals) (Buttke et al., 2012, Grindler et al., 2015) and socio-economic conditions 
369 during early life and adolescence, such as childhood growth and childhood adversities (e.g. abuse, 
370 stress, parental divorce, poverty, and obesity) (Boynton-Jarrett et al., 2013, Li et al., 2017, Mishra et 
371 al., 2009), were not accounted for in this study, which may have significant impact on adult health 
372 behaviours as well as on the timing of menarche and menopause.
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373
374 One strength of InterLACE is the access granted to individual-level data from international studies, 
375 which facilitates a detailed investigation of heterogeneity in reproductive events across and within 
376 studies without being subject to the potential for ecological fallacy. The use of individual-level data 
377 has enabled harmonisation of variables using common definitions, coding, and adjustment in the 
378 analysis. The scale of this study, which covers populations from Australia, Europe, North Africa, 
379 Middle East, USA, and Japan, provides greater statistical power and diversity in the study sample 
380 than any individual study within InterLACE. This results in both more robust overall estimates and 
381 more detailed estimates for subpopulations, such as birth cohorts and racial/ethnic groups. It has 
382 women from a range of occupational backgrounds, from professional employment to unpaid work. 
383 In light of all these aspects, the results are likely to be generalizable to most mid-age women in high 
384 and some middle-income countries.
385
386 It should be noted that a single stage model could not be fitted to InterLACE data, as the data were 
387 highly unbalanced with respect to several of the key covariates. Instead, we used a two-stage method 
388 of analysis whereby the adjustment for confounders was made using individual-level data within each 
389 study at the first stage, and then the study-specific outcome means were pooled at the second stage, 
390 so that meta-analytic results were obtained for the main outcomes and the major factors affecting 
391 heterogeneity. Given the large number of participants in each study and the use of individual-level 
392 data for estimating the effect of covariates, it is reasonable to expect that if a one-stage analysis with 
393 similar assumptions had been possible, the results would have been very similar (Burke et al., 2017).  
394 This approach extends previous methods, where the similarity of results for one-stage and two-stage 
395 methods has been demonstrated for case-control studies (Stukel et al., 2001) and clinical trials (Berlin 
396 et al., 2002, Tierney et al., 2015). 
397
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398 This study provided findings for the broad generation of women who have lived through a unique set 
399 of circumstances and now increasingly face the chronic diseases of older age. Although some women 
400 would have endured hardship in their early life, such as wartime food rationing, most participants 
401 experienced the relative prosperity of the post-war years. This was the first generation to have access 
402 to advanced birth control measures, including oral contraceptives, with concomitant social changes 
403 signified by their increasing participation in the workforce, higher educational attainment, and 
404 delayed childbirth, as is exemplified by women in the study born since the 1970s. They thus provide 
405 an indication of what might be expected from the cohort of women now experiencing similar 
406 socioeconomic changes in developing countries, and also set a baseline of evidence about the timing 
407 of events along the reproductive axis to allow for comparison with the current generations of 
408 premenopausal women.
409
410 By identifying both variations in the timing of reproductive characteristics within and between 
411 populations and in relation to environmental factors, this global consortium study strengthens the 
412 evidence base on key reproductive indices that have implications for the provision of future health 
413 services. The results also advance understanding of the potential impact of social changes now 
414 occurring in low- and middle-income countries on womens reproductive characteristics. 
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Figure legends 
Fig. 1. Mean ages at (A) menarche (n=493,395), (B) first birth (among parous women, n=384,925) 
and (C) natural menopause (among postmenopausal women, n=172,125) in the InterLACE 
Consortium. Mean ages were estimated in each study (accounting for design weights if available), 
and the estimates from each study were combined using random-effects meta-analysis. Median 
(interquartile range, IQR) ages were also presented for each study. Data on age at first birth were only 
included in the analysis from women aged N)* years at last follow-up and data on age at natural 
menopause only from women aged N66 years at last follow-up.  
Fig. 2. Mean age at menarche (n=493,395) stratified by (A) year of birth (p for trend=0.0014) and 
(B) racial/ethnic/regional group, with the estimates mutually adjusted. Mean age at menarche was 
stratified by birth year and race/ethnicity/region in each study and mutually adjusted (i.e. birth year 
and race/ethnicity/region) using linear regression models (accounting for design weights if available), 
and the adjusted estimates from each study were combined using random-effects meta-analysis for 
each category of covariates.
Fig. 3. Proportion of women with no children among women aged N)* years at last follow-up 
(n=453,515) stratified by (A) year of birth (p for trend=0.37), (B) racial/ethnic/regional group, and 
(C) education level (p for trend=0.0395). Proportion of nulliparity was stratified by birth year, 
race/ethnicity/region, and education level in each study (accounting for design weights if available), 
and the unadjusted estimates from each study were combined using random-effects meta-analysis for 
each category of variables.
Fig. 4. Mean age at first birth among parous women aged N)* years at last follow-up (n=384,925) 
stratified by (A) year of birth (p for trend=0.87), (B) racial/ethnic/regional group, and (C) education 
level (p for trend=0.0031), with the estimates mutually adjusted. Mean age at first birth was stratified 
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by birth year, race/ethnicity/region, and education level in each study and mutually adjusted (i.e. birth 
year, race/ethnicity/region, and education level) using linear regression models (accounting for design 
weights if available), and the adjusted estimates from each study were combined using random-effects 
meta-analysis for each category of covariates.
Fig. 5. Mean age at natural menopause among postmenopausal women aged N66 years at last follow-
up (n=172,125) stratified by (A) year of birth (p for trend=0.26), (B) racial/ethnic/regional group, and 
(C) education level (p for trend=0.012), with the estimates mutually adjusted and additionally 
adjusted for smoking status and BMI. Mean age at natural menopause was stratified by birth year, 
race/ethnicity/region, and education level in each study and mutually adjusted (i.e. birth year, 
race/ethnicity/region, and education level) and additionally adjusted for smoking status and BMI 
using linear regression models (accounting for design weights if available), and the adjusted estimates 
from each study were combined using random-effects meta-analysis for each category of covariate.
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1Table 1. Study-specific characteristics on age at baseline, age at last follow-up and womens year of birth for 23 studies included in the InterLACE Consortium (N = 
505,147)
Womens year of birth
Age at baseline
Age at last 
follow-up* <1930 1930-39 1940-49 1950-59 1960-69 /-(&
Study Country N Median (IQR) Median (IQR) n (%) n (%) n (%) n (%) n (%) n (%)
Australian Longitudinal Study on 
Womens Health (ALSWH 1946-51)
Australia 12,223 47.6 (46.3, 48.9) 63.6 (62.1, 65.3) N/A N/A 9,041 (74.0) 3,182 (26.0) N/A N/A
Australian Longitudinal Study on 
Womens Health (ALSWH 1973-78)
Australia 9,585 39.6# (38.4, 40.9) 39.6 (38.4, 40.9) N/A N/A N/A N/A N/A 9,585 (100)
Healthy Aging of Women Study 
(HOW)
Australia 520 55.0 (53.0, 57.0) 62.0 (60.0, 65.5) N/A N/A 460 (88.5) 60 (11.5) N/A N/A
Melbourne Collaborative Cohort 
Study (MCCS)
Australia 24,423 55.2 (47.6, 62.4) 64.4 (56.9, 71.1) 6,006 (24.6) 8,247 (33.8) 7,744 (31.7) 2,425 (9.9) 1 (0.0) N/A
Danish Nurse Cohort Study    
(DNCS)
Denmark 28,573 50.0 (47.0, 58.0) 63.0 (49.0, 70.0) 4,085 (14.3) 7,561 (26.5) 10,278 (36.0) 6,649 (23.3) N/A N/A
Womens Lifestyle and Health Study 
(WLHS)
Sweden 48,691 40.0 (35.0, 45.0) 48.0 (43.0, 54.0) N/A N/A 19,531 (40.1) 23,883 (49.1) 5,277 (10.8) N/A
French Three-City Study             
(French 3C) 
France 4,255 73.9 (69.9, 78.3) 73.9 (69.9, 78.3) 3,071 (72.2) 1,184 (27.8) N/A N/A N/A N/A
MRC National Survey of Health and 
Development (NSHD)
UK 1,898 47.0# (47.0, 47.0) 54.0 (54.0, 54.0) N/A N/A 1,898 (100) N/A N/A N/A
National Child Development Study 
(NCDS)
UK 6,752 50.0# (50.0, 50.0) 55.0 (55.0, 55.0) N/A N/A N/A 6,752 (100) N/A N/A
1970 British Cohort Study         
(BCS70)
UK 3,468 42.0# (42.0, 42.0) 42.0 (42.0, 42.0) N/A N/A N/A N/A N/A 3,468 (100)
English Longitudinal Study of 
Ageing (ELSA)
UK 6,364 57.0 (51.0, 66.0) 65.0 (58.0, 74.0) 861 (13.5) 1,411 (22.2) 2,059 (32.4) 1,858 (29.2) 162 (2.5) 13 (0.2)
UK Womens Cohort Study 
(UKWCS)
UK 34,771 51.0 (44.7, 59.4) 53.5 (46.8, 61.9) 2,937 (8.4) 8,032 (23.1) 12,515 (36.0) 11,067 (31.8) 219 (0.6) 1 (0.0)
Whitehall II Study             
(WHITEHALL)
UK 1,779 47.0 (41.0, 52.0) 63.8 (59.0, 69.6) 1 (0.1) 909 (51.1) 762 (42.8) 107 (6.0) N/A N/A
Southall And Brent Revisited 
(SABRE) 
UK 485 57.0 (53.0, 60.0) 61.0 (56.0, 72.0) 97 (20.0) 324 (66.8) 64 (13.2) N/A N/A N/A
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Age at baseline
Age at last 
follow-up* <1930 1930-39 1940-49 1950-59 1960-69 /-(&
Study Country N Median (IQR) Median (IQR) n (%) n (%) n (%) n (%) n (%) n (%)
Hilo Womens Health Study    
(HILO)
USA 975 51.0 (46.1, 55.6) 51.0 (46.1, 55.6) N/A 3 (0.3) 262 (26.9) 507 (52.0) 203 (20.8) N/A
Study of Womens Health across the 
Nation (SWAN)
USA 3,284 46.0 (44.0, 48.0) 54.0 (52.0, 57.0) N/A N/A 1,302 (39.6) 1,982 (60.4) N/A N/A
Seattle Midlife Womens Health 
Study (SMWHS)
USA 507 41.2 (38.0, 44.4) 44.8 (40.2, 49.7) N/A 23 (4.5) 227 (44.8) 257 (50.7) N/A N/A
Decisions at Menopause Study 
(DAMESUSA)
USA 293 50.0 (48.0, 53.0) 50.0 (48.0, 53.0) N/A N/A 109 (37.2) 184 (62.8) N/A N/A
Decisions at Menopause Study 
(DAMELebanon)
Lebanon 298 50.0 (48.0, 53.0) 50.0 (48.0, 53.0) N/A N/A 231 (77.5) 67 (22.5) N/A N/A
Decisions at Menopause Study 
(DAMESSpain)
Spain 298 50.0 (47.0, 53.0) 50.0 (47.0, 53.0) N/A N/A 87 (29.2) 211 (70.8) N/A N/A
Decisions at Menopause Study 
(DAMESMorocco)
Morocco 273 49.0 (46.0, 52.0) 49.0 (46.0, 52.0) N/A N/A 143 (52.4) 130 (47.6) N/A N/A
Japanese Nurses Health Study 
(JNHS)
Japan 47,745 42.0 (36.0, 48.0) 42.0 (36.0, 48.0) 1 (0.0) 118 (0.2) 4,993 (10.5) 15,979 (33.5) 20,457 (42.8) 6,197 (13.0)
UK Biobank
(UK Biobank)
UK 267,687 58.0 (50.0, 63.0) 58.0 (50.0, 63.0) N/A 9,012 (3.4) 113,913 (42.6) 89,372 (33.4) 55,306 (20.7) 84 (0.0)
Overall 505,147 52.0 (45.0, 61.0) 55.0 (47.0, 63.0) 17,059 (3.4) 36,824 (7.3) 185,619 (36.7) 164,672 (32.6) 81,625 (16.2) 19,348 (3.8)
Abbreviations: IQR, interquartile range; N/A, not applicable.
* Age at last follow-up was only based on the data availability to the InterLACE consortium. 
   	
     ff fi flge 18-23) and was followed every 3-4 years until 2015 (age 37-42). Information on age at menarche was collected in 2000, 
and fertility history was collected at regular follow-ups. The current study included 9,585 women who had available data on age at menarche or had participated in the midlife survey 
in 2015 and used their midlife age as baseline age. NSHD (1946 British Birth Cohort) and NCDS (1958 British Birth Cohort) collected prospective information on age at menarche 
and fertility history at regular follow-ups. In NSHD, age of menopause was collected first in 1989 (age 43), annually 47-54 years and at 60-64 years. In NCDS, information on age of 
menopause was obtained in 2008 (age 50). These survey years around midlife (age 47 and age 50, respectively) were therefore used as baseline. Similarly, for the BCS70 (1970 
British Cohort study), we included 3,468 women who had completed the latest survey in 2012 and used age 42 as baseline age.   
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3Table 2. Study-specific distribution of racial/ethnic/regional groups across 23 studies included in the InterLACE Consortium (N = 505,147)
Racial/ethnic/regional groups*
Study N
Caucasian
(AU)
n (%)
Caucasian
(EU)
n (%)
Caucasian
(USA)
n (%)
African/
Black 
(EU/USA)
n (%)
Japanese      
(AU/UK/USA)
n (%)
Japanese   
(Japan)
n (%)
Chinese
(AU/UK/USA)
n (%)
South 
Asian
(AU/UK)
n (%)
Southeast  
Asian 
(AU/UK/USA)
n (%)
Middle   
Eastern
(AU/UK/ME)
n (%)
Hispanic/
Latino
(AU/UK/USA) 
n (%)
Other
n (%)
ALSWH 1946-51 12,223 9,602 (78.6) 2,034(16.6) 83 (0.7) N/A 8 (0.1) N/A 43 (0.4) 58 (0.5) 172 (1.4) 22 (0.2) 33 (0.3) 168 (1.4)
ALSWH 1973-78 9,585 8,921 (93.1) 235 (2.5) 20 (0.2) N/A 1 (0.0) N/A 50 (0.5) 9 (0.1) 131 (1.4) 19 (0.2) 15 (0.2) 184 (1.9)
HOW 520 431 (82.9) 66 (12.7) N/A N/A N/A N/A N/A N/A 3 (0.6) N/A N/A 20 (3.8)
MCCS 24,423 17,333 (71.0) 7,090 (29.0) N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
DNCS 28,573 N/A 28,573 (100) N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
WLHS 48,691 N/A 48,691 (100) N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
French 3C 4,255 N/A 3,912 (91.9) 9 (0.2) 319 (7.5) N/A N/A N/A N/A N/A N/A N/A 15 (0.4)
NSHD 1,898 N/A 1,898 (100) N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
NCDS 6,752 N/A 6,652 (98.5) N/A 26 (0.4) N/A N/A N/A 25 (0.4) N/A N/A N/A 49 (0.7)
BCS70 3,468 N/A 3,394 (97.9) N/A 9 (0.3) N/A N/A N/A 39 (1.1) N/A N/A N/A 26 (0.7)
ELSA 6,364 N/A 6,175 (97.0) N/A 44 (0.7) N/A N/A 1 (0.0) 14 (0.2) N/A 2 (0.0) 1 (0.0) 127 (2.0)
UKWCS 34,771 N/A 34,327 (98.7) N/A 53 (0.2) N/A N/A 22 (0.1) 164 (0.5) N/A N/A N/A 205 (0.6)
WHITEHALL 1,779 N/A 1,567 (88.1) N/A N/A N/A N/A N/A N/A N/A N/A N/A 212 (11.9)
SABRE 485 N/A 261 (53.8) N/A 128 (26.4) N/A N/A N/A 96 (19.8) N/A N/A N/A N/A
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4Racial/ethnic/regional groups*
Study N
Caucasian
(AU)
n (%)
Caucasian
(EU)
n (%)
Caucasian
(USA)
n (%)
African/
Black 
(EU/USA)
n (%)
Japanese      
(AU/UK/USA)
n (%)
Japanese   
(Japan)
n (%)
Chinese
(AU/UK/USA)
n (%)
South 
Asian
(AU/UK)
n (%)
Southeast  
Asian 
(AU/UK/USA)
n (%)
Middle   
Eastern
(AU/UK/ME)
n (%)
Hispanic/
Latino
(AU/UK/USA) 
n (%)
Other
n (%)
HILO 975 N/A N/A 235 (24.1) 1 (0.1) 290 (29.7) N/A 9 (0.9) N/A 30 (3.1) N/A 9 (0.9) 401 (41.1)
SWAN 3,284 N/A N/A 1,542 (47.0) 928 (28.3) 280 (8.5) N/A 250 (7.6) N/A N/A N/A 284 (8.6) N/A
SMWHS 507 N/A N/A 391 (77.1) 58 (11.4) N/A N/A N/A N/A N/A N/A 6 (1.2) 52 (10.3)
DAMESUSA 293 N/A N/A 276 (94.2) 6 (2.0) N/A N/A N/A N/A N/A N/A 3 (1.0) 8 (2.7)
DAMESLebanon 298 N/A N/A N/A N/A N/A N/A N/A N/A N/A 298 (100) N/A N/A
DAMESSpain 298 N/A 287 (96.3)  N/A N/A N/A N/A N/A N/A N/A N/A 11 (3.7) N/A
DAMESMorocco 273 N/A N/A N/A N/A N/A N/A N/A N/A N/A 273 (100) N/A N/A
JNHS 47,745 N/A N/A N/A N/A N/A 47,745 (100) N/A N/A N/A N/A N/A N/A
UK Biobank 267,687 470 (0.2) 252,672 (94.4) 974 (0.4) 5,130 (1.9) 211 (0.1) N/A 964 (0.4) 3,980 (1.5) 469 (0.2) 351 (0.1) 339 (0.1) 2,127 (0.8)
Overall 505,147 36,757 (7.3) 397,834 (78.8) 3,530 (0.7) 6,702 (1.3) 790 (0.2) 47,745 (9.5) 1,339 (0.3) 4,385 (0.9) 805 (0.2) 965 (0.2) 701 (0.1) 3,594 (0.7)
Abbreviations: AU, Australia; EU, Europe; ME, Middle East; N/A, not applicable.
* Race/ethnicity was derived from self-identified racial/ethnic background reported in 13 studies. For the remaining studies, race/ethnicity was defined based on the reported country 
of birth, the language spoken at home, or the country where the study was conducted (residency).
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5Table 3. Study-specific distribution of number of children across 23 studies included in the InterLACE 
Consortium (N = 453,515)*
Number of children among parous women (n=379,344)
Study N
Women with no
children (%)
One
child (%)
Two
children (%)
Three or more
children (%)
Median
(IQR)
ALSWH 1946-51 11,781 7.2 9.2 42.8 48.0 2.0 (2.0-3.0)
ALSWH 1973-78 2,528 18.8 14.9 50.3 34.9 2.0 (2.0-3.0)
HOW N/A N/A N/A N/A N/A N/A
MCCS 24,396 14.0 9.7 36.6 53.8 3.0 (2.0, 3.0)
DNCS 28,501 14.9 14.4 49.1 36.5 2.0 (2.0, 3.0)
WLHS 41,365 9.7 14.8 49.6 35.6 2.0 (2.0, 3.0)
French 3C 3,845 15.9 23.1 32.8 44.1 2.0 (2.0, 3.0)
NSHD 1,175 11.9 14.0 51.3 34.7 2.0 (2.0, 3.0)
NCDS 3,824 13.4 17.0 53.1 29.9 2.0 (2.0, 3.0)
BCS70 2,598 21.3 21.8 54.5 23.7 2.0 (2.0-2.0)
ELSA 6,111 12.7 18.5 45.7 35.8 2.0 (2.0, 3.0)
UKWCS 27,385 13.2 15.7 50.1 34.2 2.0 (2.0, 3.0)
WHITEHALL 1,498 46.0 28.2 44.0 27.8 2.0 (1.0, 3.0)
SABRE 159 10.7 18.3 28.2 53.5 3.0 (2.0, 4.0)
HILO 955 12.3 18.1 43.2 38.7 2.0 (2.0, 3.0)
SWAN 3,244 16.7 19.9 40.5 39.7 2.0 (2.0, 3.0)
SMWHS 390 25.9 23.5 42.6 33.9 2.0 (2.0, 3.0)
DAMES USA N/A N/A N/A N/A N/A N/A
DAMES Lebanon 296 1.4 3.4 9.9 86.6 4.0 (3.0, 5.0)
DAMES Spain 298 22.5 17.8 54.1 28.1 2.0 (2.0, 3.0)
DAMES Morocco 273 7.0 5.5 9.8 84.7 4.0 (3.0, 6.0)
JNHS 26,526 15.2 12.6 52.6 34.8 2.0 (2.0, 3.0)
UK Biobank 266,367 18.5 16.4 53.9 29.7 2.0 (2.0, 3.0)
Overall 453,515 16.4 15.4 51.0 33.6 2.0 (2.0, 3.0)
Abbreviations: IQR, interquartile range; N/A, not applicable.
* Data on parity were only included in the analysis from women aged /'& years at last follow-up.  
Page 60 of 68
http://humrep.oupjournals.org
Draft Manuscript Submitted to Human Reproduction for Peer Review
 Fig. 1. Mean ages at (A) menarche (n=493,395), (B) first birth (among parous women, n=384,925) and (C) 
natural menopause (among postmenopausal women, n=172,125) in the InterLACE Consortium. Mean ages 
were estimated in each study (accounting for design weights if available), and the estimates from each 
study were combined using random-effects meta-analysis. Median (interquartile range, IQR) ages were also 
presented for each study. Data on age at first birth were only included in the analysis from women aged 
12 years at last follow-up and data on age at natural menopause only from women aged 1 years at last 
follow-up.   
175x254mm (300 x 300 DPI) 
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 Fig. 2. Mean age at menarche (n=493,395) stratified by (A) year of birth (p for trend=0.0014) and (B) 
racial/ffi nic/!egional group, with the estimates mutually adj"$ffid. Mean age at menarche was stratified by 
birth year and racffi/ffi %ic&'/!ffi(&)% in each study and mutually a*j"$ffid (i.e. birth year and 
racffi/ffi %&c&'/!ffi(&)%+ "sing linear regression models (accounting for design weights if available), and the 
a*
j"$ffid estimates from each study were combined using random-effects meta-analysis for each category of 
covariates. 
129x175mm (300 x 300 DPI) 
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 Fig. 3. Proportion of women with no children among women aged  years at last follow-up (n=453,515) 
stratified by (A) year of birth (p for trend=0.37), (B) r,-.,01et23.-1456.73,0 64oup, and (C) education level (p 
for trend=0.0395). Proportion of nulliparity was stratified by birth year, race15t23.-.ty1region, and education 
level in each study (accounting for design weights if available), and the unad8usted estimates from each 
study were combined using random-effects meta-analysis for each category of variables. 
125x249mm (300 x 300 DPI) 
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 Fig. 4. Mean age at first birth among parous women aged  years at last follow-up (n=384,925) stratified 
by (A) year of birth (p for trend=0.87), (B) r9:;9<=>?@A;:=B>C;DA9< CBoup, and (C) education level (p for 
trend=0.0031), with the estimates mutually aEFusted. Mean age at first birth was stratified by birth year, 
ra:>=>?@A;:;?G=B>C;DAH and education level in each study and mutually 9EFIJ?>E (i.e. birth year, 
ra:>=>?@A;:;?
G
=B>C;DA
H
and education level) using linear regression models (accounting for design weights if 
available), and the 9
EFIJ
?>d estimates from each study were combined using random-effects meta-analysis 
for each category of covariates. 
128x253mm (300 x 300 DPI) 
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 Fig. 5. Mean age at natural menopause among postmenopausal women aged  years at last follow-up 
(n=172,125) stratified by (A) year of birth (p for trend=0.2KLM NO) racialPQRSTUVPregional group, and (C) 
education level (p for trend=0.012), with the estimates mutually aWXusted and additionally aWXusted for 
sYZ[ing status and BMI. Mean age at natural menopause was stratified by birth year, raVQPQRSTUVURyP\Q]UZTM
and education level in each study and mutually ^
WX
_
s
RQd (i.e. birth year, raVQPQRSTUVUR`P
\
Q
]
U
Z
TM and 
education level) and additionally ^
WX
_
s
RQ
W
for 
sYZ[
UT
] s
R^tus and BMI using linear regression models 
(accounting for design weights if available), and the ^WX_sRQd estimates from each study were combined 
using random-effects meta-analysis for each category of covariate. 
125x251mm (300 x 300 DPI) 
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Lifestyle and Health Study (WLHS) was funded by a grant from the Swedish Research Council 
(Grant number 521-2011-2955). MRC National Survey of Health and Development (NSHD) 
has core funding from the UK Medical Research Council (MC UU 12019/1). National Child 
Development Study (NCDS) and 1970 British Cohort Study (BCS 70) are funded by the UK 
Economic and Social Research Council. English Longitudinal Study of Ageing (ELSA) is 
funded by the National Institute on Aging (Grants 2RO1AG7644 and 2RO1AG017644-01A1) 
and a consortium of UK government departments. UK Womens Cohort Study (UKWCS) was 
originally funded by the World Cancer Research Fund. The Whitehall II study is supported by 
grants from the Medical Research Council (K013351), British Heart Foundation (BHF 
RG/16/11/32334) and US National Institutes on Aging (R01AG013196, R01AG034454). The 
main Southall And Brent Revisited (SABRE) study is supported by a joint programme grant 
from the Wellcome Trust and British Heart Foundation (BHF). Hilo Womens Health Study 
(HILO) was supported by NIH grant 5 S06 GM08073-26. Seattle Midlife Womens Health 
Study (SMWHS) was supported in part by grants from the National Institute of Nursing 
Research, P50-NU02323, P30-NR04001, and R01-NR0414. Baseline survey of the Japanese 
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Nurses Health Study (JNHS) was supported in part by a Grant-in-Aid for Scientific Research 
(B: 14370133, 18390195) from the Japan Society for the Promotion of Science, and by the 
grants from the Japan Menopause Society. The Decisions at Menopause Study (DAMES) 
project was supported by a grant from the National Science Foundation Behavioral Science 
Branch (SBR-9600721), and by a grant from the National Institutes of Health/ National 
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Three-City Study is conducted under a partnership agreement between the Institut National de 
la et de la Recherche  (INSERM), the Victor Segalen-Bordeaux II University 
and Sanofi-Aventis. The Fondation pour la Recherche funded preparation and 
initiation of the study. The Three-City Study is also supported by the Caisse Nationale Maladie 
des Travailleurs Sal Direction e de la MGEN, Institut de la 
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research has been conducted using the UK Biobank resource under application 26629. 
The Study of Womens Health Across the Nation (SWAN) has grant support from the National 
Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA), the National 
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(ORWH) (Grants U01NR004061; U01AG012505, U01AG012535, U01AG012531, 
U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495). The 
content of this article is solely the responsibility of the authors and does not necessarily 
represent the official views of the NIA, NINR, ORWH or the NIH. 
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